Suvretta Capital Management »

Arcus Biosciences Incorporated shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $11M 597k 17.95

More positions owned by Suvretta Capital Management

Royalty Pharma Shs Class A (RPRX)
Biohaven (BHVN)
Arcellx Common Stock (ACLX)
Horizon Therapeutics Pub L SHS
Insmed Com Par $.01 (INSM)
Meta Platforms Cl A (META)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Intra Cellular Therapies (ITCI)
Microsoft Corporation (MSFT)
Kura Oncology (KURA)
Wynn Resorts (WYNN)
Marinus Pharmaceuticals Com New (MRNS)
89bio (ETNB)
General Electric Com New (GE)

View all positions for Suvretta Capital Management

Top funds holding Arcus Biosciences Incorporated

Vanguard Group
Octagon Capital Advisors
Invus Financial Advisors
Boxer Capital
Dimensional Fund Advisors
Alliancebernstein
Decheng Capital
Point72 Asset Management
Goldman Sachs Group
Bnp Paribas Investment Partners
Balyasny Asset Management
Charles Schwab Investment Management
Bank of New York Mellon
Ikarian Capital
Ubs Global Asset Management Americas

View all funds holding Arcus Biosciences Incorporated